Serum Interleukin 23 and Nitric Oxide in Vitiligo: New insights into the emerging association with VASI Score

Document Type : Original Article

Authors

1 Dermatololgy &Veneorology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt.

2 Dermatology and Venereology Department,faculty of medicine ,zagazig university,sharqia,egypt

3 Clinical Pathology Department Faculty of Medicine Zagazig University

4 Dermatology & Veneorology Department .Faculty of Medicine.Zagazig University

Abstract

Background: Vitiligo is a depigmentation disease of the skin caused by selective melanocyte degradation. In recent years, vitiligo has become known as an autoimmune disorder.
Objectives: Our objective in this study was to determine serum levels of interleukin 23 (IL-23) and nitric oxide (NO) in vitiligo patients and their possible role in the pathogenesis of vitiligo, in an attempt to identify new treatment strategies.
Methods: The autoimmune and autocytotoxic mechanisms of vitiligo development were investigated in a case-control study comparing 30 vitiligo patients to 30 healthy controls. Serum levels of IL-23 and NO were measured in vitiligo patients and healthy controls. The interactions between IL-23 and NO with different parameters in the vitiligo group were also examined.
Results: Serum IL-23 and NO levels were higher in the vitiligo group compared with healthy controls (P

Keywords

Main Subjects